Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Neuroinflammation inhibition and neuroprotective effects of purpurin, a potential anti‐AD compound, screened via network proximity and gene enrichment analyses

1 Oct 2024

Abstract excerpt

Alzheimer's disease (AD) is a complex neurodegenerative disease without any effective preventive or therapeutic drugs. Natural products with stable structures and pharmacological characteristics are valuable sources for the development of novel drugs for many complex diseases. This study aimed to discover potential natural compounds for the treatment of AD using new technologies and methods and explore the...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Alzheimer's disease research and treatments
Share to Bioinformatics and Genomic Networks
Share to Computational Drug Discovery Methods

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Source

Identifiers

PMID: 39351804
DOI: 10.1002/ptr.8064

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 1 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Neuroinflammation inhibition and neuroprotective effects of purpurin, a potential anti‐AD compound, screened via network proximity and gene enrichment analysesPMID 39351804Read ↗

Screening novel drug candidates for Alzheimer’s disease by an integrated network and transcriptome analysisSemantic proximity Read ↗

Uncovering the Oxidative Stress Mechanisms and Targets in Alzheimer's Disease by Integrating Phenotypic Screening Data and Polypharmacology Networks.Semantic proximity Read ↗

Identification of Common Molecular Signatures Shared between Alzheimer’s and Parkinson’s Diseases and Therapeutic Agents Exploration: An Integrated Genomics ApproachSemantic proximity Read ↗

Unveiling disulfidptosis-related biomarkers and predicting drugs in Alzheimer’s diseaseSemantic proximity Read ↗

Drug Repurposing for Alzheimer’s Disease Based on Protein‐Protein Interaction NetworkSemantic proximity Read ↗

A Network Pharmacology Approach to Reveal the Underlying Mechanisms of Paeonia lactiflora Pall. On the Treatment of Alzheimer’s DiseaseSemantic proximity Read ↗

Molecular Mechanism of Huanglian Jiedu Decoction in Treatment of Alzheimer’s Disease based on Network PharmacologySemantic proximity Read ↗

Identification and validation of oxidative stress and immune-related hub genes in Alzheimer’s disease through bioinformatics analysisSemantic proximity Read ↗

An Effective Method to Identify Shared Pathways and Common Factors among Neurodegenerative Diseases.Semantic proximity Read ↗

Common Dysregulated Pathways and Genes in Alzheimer’s, Parkinson’s, and Huntington’s Diseases: A Computational Analysis to Nominate Candidate Gene Targets for Drug RepurposingSemantic proximity Read ↗

Genetic networks in Parkinson’s and Alzheimer’s diseaseSemantic proximity Read ↗

Network pharmacology identify intersection genes of quercetin and Alzheimer’s disease as potential therapeutic targetsSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.